212 related articles for article (PubMed ID: 23818361)
1. Who may benefit from prophylactic cranial irradiation amongst stage III non-small cell lung cancer patients?
Alsan Cetin I; Akgun Z; Atasoy BM; Fulden Yumuk P; Abacioglu U
J BUON; 2013; 18(2):453-8. PubMed ID: 23818361
[TBL] [Abstract][Full Text] [Related]
2. Impact of prophylactic cranial irradiation timing on brain relapse rates in patients with stage IIIB non-small-cell lung carcinoma treated with two different chemoradiotherapy regimens.
Topkan E; Parlak C; Kotek A; Yuksel O; Cengiz M; Ozsahin M; Pehlivan B
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1264-71. PubMed ID: 22172902
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation.
Ji Z; Bi N; Wang J; Hui Z; Xiao Z; Feng Q; Zhou Z; Chen D; Lv J; Liang J; Fan C; Liu L; Wang L
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):330-7. PubMed ID: 24725335
[TBL] [Abstract][Full Text] [Related]
4. Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage.
Collaud S; Stahel R; Inci I; Hillinger S; Schneiter D; Kestenholz P; Weder W
Lung Cancer; 2012 Dec; 78(3):234-8. PubMed ID: 23040415
[TBL] [Abstract][Full Text] [Related]
5. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma.
Bajard A; Westeel V; Dubiez A; Jacoulet P; Pernet D; Dalphin JC; Depierre A
Lung Cancer; 2004 Sep; 45(3):317-23. PubMed ID: 15301872
[TBL] [Abstract][Full Text] [Related]
6. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
[TBL] [Abstract][Full Text] [Related]
7. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?
Carolan H; Sun AY; Bezjak A; Yi QL; Payne D; Kane G; Waldron J; Leighl N; Feld R; Burkes R; Keshavjee S; Shepherd F
Lung Cancer; 2005 Jul; 49(1):109-15. PubMed ID: 15949596
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting the risk of brain metastasis in small cell lung cancer with surgery: is prophylactic cranial irradiation necessary for stage I-III disease?
Gong L; Wang QI; Zhao L; Yuan Z; Li R; Wang P
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):196-200. PubMed ID: 22818415
[TBL] [Abstract][Full Text] [Related]
9. Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy.
Germain F; Wai ES; Berthelet E; Truong PT; Lesperance M
Am J Clin Oncol; 2008 Dec; 31(6):561-6. PubMed ID: 19060588
[TBL] [Abstract][Full Text] [Related]
10. [Whole brain irradiation for non-small-cell lung cancer with brain metastasis].
Shi AH; Zhu GY; Yu R; Ma HM; Liu CQ; Su X; Sun Y; Cai Y; Xu XN; Zhang SW; Xu B
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):545-8. PubMed ID: 18069640
[TBL] [Abstract][Full Text] [Related]
11. Management and prognosis in synchronous solitary resected brain metastasis from non-small-cell lung cancer.
Louie AV; Rodrigues G; Yaremko B; Yu E; Dar AR; Dingle B; Vincent M; Sanatani M; Younus J; Malthaner R; Inculet R
Clin Lung Cancer; 2009 May; 10(3):174-9. PubMed ID: 19443337
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer.
Patel S; Macdonald OK; Suntharalingam M
Cancer; 2009 Feb; 115(4):842-50. PubMed ID: 19117355
[TBL] [Abstract][Full Text] [Related]
13. Risk of cerebral metastases for postoperative locally advanced non-small-cell lung cancer.
Wang SY; Ye X; Ou W; Lin YB; Zhang BB; Yang H
Lung Cancer; 2009 May; 64(2):238-43. PubMed ID: 18838190
[TBL] [Abstract][Full Text] [Related]
14. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
Hu C; Chang EL; Hassenbusch SJ; Allen PK; Woo SY; Mahajan A; Komaki R; Liao Z
Cancer; 2006 May; 106(9):1998-2004. PubMed ID: 16572401
[TBL] [Abstract][Full Text] [Related]
15. Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases.
Hsiao SH; Chung CL; Chou YT; Lee HL; Lin SE; Liu HE
Lung Cancer; 2013 Nov; 82(2):319-23. PubMed ID: 24018025
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
17. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.
Mamon HJ; Yeap BY; Jänne PA; Reblando J; Shrager S; Jaklitsch MT; Mentzer S; Lukanich JM; Sugarbaker DJ; Baldini EH; Berman S; Skarin A; Bueno R
J Clin Oncol; 2005 Mar; 23(7):1530-7. PubMed ID: 15735128
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic Cranial Irradiation for Patients With Locally Advanced Non-Small-Cell Lung Cancer at High Risk for Brain Metastases.
Park HS; Decker RH; Wilson LD; Yu JB
Clin Lung Cancer; 2015 Jul; 16(4):292-7. PubMed ID: 25499149
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis.
Chidel MA; Suh JH; Greskovich JF; Kupelian PA; Barnett GH
Radiat Oncol Investig; 1999; 7(5):313-9. PubMed ID: 10580901
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
